Officials of Ebn Sina Medical and Turkish company CinnaGenIlaç during the signing event, in Doha.
DOHA: Aamal Company and its fully owned subsidiary, Ebn Sina Medical, announced yesterday distribution agreement with Turkish Company CinnaGenIlaç. The deal involves importing several biotech drugs to Qatar used for medical treatment of multiple sclerosis, rheumatoid arthritis, cancer, and blood diseases.
The signing ceremony took place in Doha, with the attendance of Turkey’s ambassador to Qatar FikretÖzer, and CEO of CinnaGenIlaç’ Dr Ferhat Farsi and General Manager of Ebn Sina Medical, Sherif Shehata.
Sheikh Mohamed Bin Faisal Al Thani, Vice Chairman and Managing Director of Aamal Company said: “We are very pleased to announce this agreement with CinnaGenIlaç, which reflects Aamal’s persistence on exploring new international markets and creating cooperative relationshipswith companies that go in line withthe quality standards of Aamal has set for its products. We are positive that this deal will support Ebn Sina’s organic growth, which include being alert to the market demands and adopt a proactive approach partnering with leading institutions to provide the local market with the best and latestpharmaceutical productsto meet the increasing market needs”.
Sherif Shehata, General Manager of Ebn Sina Medical added: “I’m pleased to announce this partnership with a leading pharmaceutical firm such as CinnaGenIlaç. As we reveal this agreement, we express our determination and commitment to secure medicine availability in Qatar – based on the recommendations of the Ministry of Health – from different resources, including Turkey, which has shown strong support to the Qatari market in the status quo. Our deal with CinnaGenIlaç came after careful search for a well-establish partner in Turkey to provide us with such an excellent opportunity to expand our product offering”.
Ebn Sina Medical is an ISO Certified subsidiary of Aamal Company and the leading pharmaceutical distribution company in Qatar having exclusive distribution agreements with several international pharmaceutical companies. It is active in the importation, distribution, promotion and retailing of pharmaceuticals, appliances and disposables in addition to consumer products. Ebn Sina Medical provides complete professional services to government departments, retail pharmacies, private clinics, industrial companies and the local market. Aamal has a 100 percent interest in Ebn Sina Medical.
